Riskpilot← Back to searchSign inGet full accessCHIROFORM A/S
A/SActiveCVR 26672724Mariendalsvej 22Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20025 employees
Revenue 2025
DKK 1,4M
-7% vs 2024
EBITDA margin
14.4%
-38% vs 2024
Equity ratio
60.0%
Financial strength
Net profit 2025
DKK 68K
-61% vs 2024
| Revenue | DKK 1,4M | -7% |
| EBITDA | DKK 201K | -38% |
| Net profit | DKK 68K | -61% |
| Total assets | DKK 3,5M | -6% |
| Equity | DKK 2,1M | +3% |
| Employees | 5 | — |
Legal name
CHIROFORM A/S
CVR number
26672724
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. januar 2002
Share capital
DKK 500.000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren.
Company purpose
Selskabets formål er handel med medicinalvarer, sygeplejeartikler, fitnessanlæg og dermed beslægtet virksomhed.
Address
Mariendalsvej 22
Phone
+4586613611
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.272 | 1.083 | 1.413 | 1.132 | 1.619 | 1.742 | 1.579 | 1.444 | 2.061 | 1.676 | 1.276 | 1.293 | 1.501 | 1.392 |
| Staff expenses | -1.057 | -1.005 | -1.035 | -939 | -990 | -1.048 | -1.084 | -1.133 | -1.388 | -1.253 | -1.182 | -1.142 | -1.176 | -1.191 |
| EBITDA | 215 | 78 | 379 | 193 | 628 | 695 | 495 | 321 | 673 | 423 | 93 | 151 | 325 | 201 |
| Depreciation & amort. | 61 | -57 | -69 | -69 | -69 | -89 | -57 | 5 | -33 | -33 | -15 | -13 | -12 | -26 |
| EBIT | 154 | 21 | 310 | 124 | 560 | 606 | 437 | 316 | 640 | 390 | 78 | 139 | 313 | 175 |
| Net financials | -116 | -131 | -129 | -109 | -103 | -85 | -58 | -64 | -46 | -23 | -37 | -94 | -88 | -87 |
| Profit before tax | 38 | -57 | 181 | 16 | 457 | 521 | 379 | 252 | 594 | 367 | 41 | 45 | 225 | 88 |
| Tax | 10 | 26 | 44 | 0 | 106 | 115 | 86 | 56 | 131 | 81 | 11 | 11 | 51 | 20 |
| Net profit | 28 | -83 | 137 | 16 | 351 | 406 | 294 | 197 | 463 | 286 | 30 | 34 | 174 | 68 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3.305 | 2.900 | 3.034 | 2.633 | 2.850 | 3.124 | 2.970 | 3.164 | 3.662 | 3.224 | 3.978 | 3.624 | 3.752 | 3.518 |
| Equity | 396 | 313 | 400 | 416 | 928 | 1.035 | 1.178 | 1.375 | 1.838 | 1.924 | 1.834 | 1.868 | 2.041 | 2.109 |
| Long-term debt | 843 | 708 | 599 | 477 | 233 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.990 | 1.829 | 1.989 | 1.704 | 1.622 | 2.043 | 1.758 | 1.755 | 1.800 | 1.283 | 2.116 | 1.717 | 1.649 | 1.366 |
| Total debt | 2.834 | 2.537 | 2.588 | 2.181 | 1.856 | 2.043 | 1.758 | 1.755 | 1.800 | 1.283 | 2.116 | 1.717 | 1.649 | 1.366 |
EBITDA margin
14.4%
This company
15.8%
Market median
-9% vs market
20122025
Equity ratio
60.0%
This company
38.2%
Market median
+57% vs market
20122025
Return on equity
3.2%
This company
18.4%
Market median
-83% vs market
20122025
Net profit margin
4.9%
This company
8.1%
Market median
-40% vs market
20122025
Asset turnover
0.40×
This company
1.12×
Market median
-64% vs market
20122025
Debt / equity
0.67×
This company
0.62×
Market median
+8% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JH Management | Management | 2002 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2006 | — | — | |
| Chairman | 2006 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
HAURITS HOLDING ApS | Company | 100.0% | 100.0% | 2004 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HAURITS HOLDING ApS
CHIROFORM A/S Board members of CHIROFORM A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Haurits | Management | 0 companies |
| Ole Anders Petersen | Board of Directors | 0 companies |
| Ivan Høeg | Chairman | 0 companies |